4-HO-MET: Difference between revisions
>Agile m →Pharmacology: Added information about SRI properties. |
>Agile m Updated dangerous interactions with possibility of serotonin syndrome from its SRI properties. |
||
Line 199: | Line 199: | ||
{{DangerousInteractions/Psychedelics}} | {{DangerousInteractions/Psychedelics}} | ||
===[[Serotonin syndrome]] risk=== | |||
Combinations with the following substances can lead to dangerously high [[serotonin]] levels. Serotonin syndrome requires immediate medical attention and can be fatal if left untreated. | |||
*'''[[DangerousInteraction::MAOIs|MAOIs]]''' such as '''[[syrian rue]]''', '''[[banisteriopsis caapi]]''', '''phenelzine''', '''selegiline''', and '''moclobemide'''<ref>Gillman, P. K. (2005). Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. British Journal of Anaesthesia, 95(4), 434-441. https://doi.org/10.1093/bja/aei210</ref> - MAO-B inhibitors can increase the potency and duration of phenethylamines unpredictably. MAO-A inhibitors with MDMA will lead to hypertensive crises. | |||
*'''[[UnsafeInteraction::Serotonin releasers]]''' such as '''[[MDMA]]''', '''[[4-FA]]''', '''[[methamphetamine]]''', '''[[methylone]]''' and '''[[αMT]]''' | |||
*'''[[UncertainInteraction::ΑMT|AMT]]''' | |||
*'''[[UnsafeInteraction::2C-T-x|2C-T-x]]''' | |||
*'''[[DangerousInteraction::DXM|DXM]]''' | |||
*'''[[UnsafeInteraction::5-HTP|5-HTP]]''' | |||
==Legal status== | ==Legal status== | ||